132 related articles for article (PubMed ID: 38507012)
1. Assessment of Temperature-Dependent Drug Release of Solubilizing Nanoformulations Using the SITUA.
Stern ST; Skoczen SL; Park YH
Methods Mol Biol; 2024; 2789():301-311. PubMed ID: 38507012
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing Pharmacokinetics of Marketed Nanomedicine Formulations Using a Stable Isotope Tracer Assay.
Skoczen SL; Snapp KS; Crist RM; Kozak D; Jiang X; Liu H; Stern ST
ACS Pharmacol Transl Sci; 2020 Jun; 3(3):547-558. PubMed ID: 32566919
[TBL] [Abstract][Full Text] [Related]
3. Improved Ultrafiltration Method to Measure Drug Release from Nanomedicines Utilizing a Stable Isotope Tracer.
Skoczen SL; Stern ST
Methods Mol Biol; 2018; 1682():223-239. PubMed ID: 29039106
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane® in rodent and non-human primate models using a stable isotope tracer assay.
Hwang D; Vinod N; Skoczen SL; Ramsey JD; Snapp KS; Montgomery SA; Wang M; Lim C; Frank JE; Sokolsky-Papkov M; Li Z; Yuan H; Stern ST; Kabanov AV
Biomaterials; 2021 Nov; 278():121140. PubMed ID: 34634661
[TBL] [Abstract][Full Text] [Related]
5. Stable isotope method to measure drug release from nanomedicines.
Skoczen S; McNeil SE; Stern ST
J Control Release; 2015 Dec; 220(Pt A):169-174. PubMed ID: 26596375
[TBL] [Abstract][Full Text] [Related]
6. Heat/pH-boosted release of 5-fluorouracil and albumin-bound paclitaxel from Cu-doped layered double hydroxide nanomedicine for synergistical chemo-photo-therapy of breast cancer.
Liu J; Liu K; Zhang L; Zhong M; Hong T; Zhang R; Gao Y; Li R; Xu T; Xu ZP
J Control Release; 2021 Jul; 335():49-58. PubMed ID: 33989692
[TBL] [Abstract][Full Text] [Related]
7. Human intestinal fluid layer separation: The effect on colloidal structures & solubility of lipophilic compounds.
Riethorst D; Mitra A; Kesisoglou F; Xu W; Tack J; Brouwers J; Augustijns P
Eur J Pharm Biopharm; 2018 Aug; 129():104-110. PubMed ID: 29802985
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory and antioxidant effects of nanoformulations composed of metal-organic frameworks delivering rutin and/or piperine natural agents.
AbouAitah K; Higazy IM; Swiderska-Sroda A; Abdelhameed RM; Gierlotka S; Mohamed TA; Szałaj U; Lojkowski W
Drug Deliv; 2021 Dec; 28(1):1478-1495. PubMed ID: 34254539
[TBL] [Abstract][Full Text] [Related]
9. Utilization of a fattigation platform gelatin-oleic acid sodium salt conjugate as a novel solubilizing adjuvant for poorly water-soluble drugs via self-assembly and nanonization.
Kim D; Park C; Meghani NM; Tran TTD; Tran PHL; Park JB; Lee BJ
Int J Pharm; 2020 Feb; 575():118892. PubMed ID: 31786354
[TBL] [Abstract][Full Text] [Related]
10. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release.
Shahein SA; Aboul-Enein AM; Higazy IM; Abou-Elella F; Lojkowski W; Ahmed ER; Mousa SA; AbouAitah K
Int J Nanomedicine; 2019; 14():5503-5526. PubMed ID: 31410001
[TBL] [Abstract][Full Text] [Related]
11. Effect of solubilizing agents on mupirocin loading into and release from PEGylated nanoliposomes.
Cern A; Nativ-Roth E; Goldblum A; Barenholz Y
J Pharm Sci; 2014 Jul; 103(7):2131-2138. PubMed ID: 24898012
[TBL] [Abstract][Full Text] [Related]
12. Pyrazolo[3,4-d]pyrimidines-loaded human serum albumin (HSA) nanoparticles: Preparation, characterization and cytotoxicity evaluation against neuroblastoma cell line.
Fallacara AL; Mancini A; Zamperini C; Dreassi E; Marianelli S; Chiariello M; Pozzi G; Santoro F; Botta M; Schenone S
Bioorg Med Chem Lett; 2017 Jul; 27(14):3196-3200. PubMed ID: 28558969
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of drug release from cubosomes using the pressure ultrafiltration method.
Boyd BJ
Int J Pharm; 2003 Jul; 260(2):239-47. PubMed ID: 12842343
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous Evaluation of Dissolution and Permeation of Oral Drug Solid Formulations for Predicting Absorption Rate-Limiting Factors and In Vitro-In Vivo Correlations: Case Study Using a Poorly Soluble Weakly Basic Drug.
Li Z; He X; Tian S; Feng G; Huang C; Xun M; Wu Z; Wang Y
AAPS PharmSciTech; 2019 Oct; 20(8):321. PubMed ID: 31650430
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of accelerated drug release testing methods for a matrix-type intravaginal ring.
Externbrink A; Eggenreich K; Eder S; Mohr S; Nickisch K; Klein S
Eur J Pharm Biopharm; 2017 Jan; 110():1-12. PubMed ID: 27793758
[TBL] [Abstract][Full Text] [Related]
16. Developing a robust ultrafiltration-LC-MS/MS method for quantitative analysis of unbound vadimezan (ASA404) in human plasma.
Li W; Lin H; Smith HT; Tse FL
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1927-33. PubMed ID: 21680264
[TBL] [Abstract][Full Text] [Related]
17. In vitro dissolution considerations associated with nano drug delivery systems.
Gupta R; Chen Y; Xie H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1732. PubMed ID: 34132050
[TBL] [Abstract][Full Text] [Related]
18. Solubility and dissolution rate enhancement of ibuprofen by cyclodextrin based carbonate nanosponges.
Shoaib QU; Latif S; Ijaz QA; Afzal H; Siddique MI; Hussain A; Arshad MS; Bukhari NI; Abbas N
Pak J Pharm Sci; 2021 May; 34(3(Supplementary)):1045-1055. PubMed ID: 34602431
[TBL] [Abstract][Full Text] [Related]
19. Cocrystal Solubility Advantage Diagrams as a Means to Control Dissolution, Supersaturation, and Precipitation.
Huang Y; Kuminek G; Roy L; Cavanagh KL; Yin Q; Rodríguez-Hornedo N
Mol Pharm; 2019 Sep; 16(9):3887-3895. PubMed ID: 31318567
[TBL] [Abstract][Full Text] [Related]
20. Drug release from nanomedicines: Selection of appropriate encapsulation and release methodology.
Wallace SJ; Li J; Nation RL; Boyd BJ
Drug Deliv Transl Res; 2012 Aug; 2(4):284-92. PubMed ID: 23110256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
